131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: A Phase II Clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital

TURNER, J. Harvey ; MARTINDALE, Andrew A ; BOUCEK, Jan ; CLARINGBOLD, Phillip G ; LEAHY, Michael F

Cancer biotherapy & radiopharmaceuticals, 2003-08, Vol.18 (4), p.513-524 [Periódico revisado por pares]

Larchmont, NY: Liebert

Texto completo disponível